Predicting the Hallucinogenic Potential of Molecules Using Artificial Intelligence
ACS Chemical Neuroscience August 2, 2024 Fabio Urbina, Thane Jones, Joshua S. Harris et al. 9 citations
The development of new drugs addressing serious mental health and other disorders should avoid the psychedelic experience. Analogs of psychedelic drugs can have clinical utility and are termed “psychoplastogens”. These represent promising candidates for treating opioid use disorder to reduce drug dependence, with rarely reported serious adverse effects. This drug abuse cessation is linked to...